Indication
Vascular Anomaly
2 clinical trials
2 products
1 drug
Clinical trial
A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)Status: Not yet recruiting, Estimated PCD: 2026-06-01
Drug
AlpelisibProduct
MirdametinibClinical trial
Treatment Protocol for the Use of the Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible LesionsStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Sirolimus